Table 1 Clinical characteristics of epithelial ovarian cancer patients in training cohort (n = 70)
Clinical features | Sen-group(n = 43) (n/%)/\(\bar {x} \pm s\) | Res-group(n = 27) (n/%)/\(\bar {x} \pm s\) | t/χ2 | p |
|---|---|---|---|---|
Age | ||||
≤ 50 years | 19(44.2) | 5(18.5) | 4.850 | 0.028 |
> 50years | 24(55.8) | 22(81.5) | ||
Maximum tumor diameter | ||||
≤ 5 cm | 13(30.2) | 13(48.1) | 2.280 | 0.131 |
> 5 cm | 30(69.8) | 14(51.9) | ||
FIGO stage | ||||
I/II | 12(27.9) | 3(11.1) | 2.779 | 0.096 |
III/IV | 31(72.1) | 24(88.9) | ||
Histopathological type | ||||
serous | 36(83.7) | 25(92.6) | 1.165 | 0.280 |
others | 7(16.3) | 2(7.4) | ||
Tumor grade | ||||
G3 | 32(74.4) | 23(85.2) | 1.142 | 0.285 |
G1-G2 | 11(25.6) | 4(14.8) | ||
Lymph node metastasis | ||||
unresected | 18(41.9) | 13(48.1) | 6.534 | 0.038 |
no | 14(32.6) | 2(7.4) | ||
yes | 11(25.6) | 12(44.4) | ||
Vascular cancer thrombus | ||||
no | 32(74.4) | 10(37.0) | 9.657 | 0.002 |
yes | 11(25.6) | 17(63.0) | ||
Ascites cancer cell | ||||
no | 22(51.2) | 4(14.8) | 9.386 | 0.002 |
yes | 21(48.8) | 23(85.2) | ||
Residual tumor size* | ||||
R0 | 27(62.8) | 11(40.7) | 4.717 | 0.095 |
R1 | 13(30.2) | 10(37.0) | ||
R2 | 3(7.0) | 6(22.2) | ||
Neoadjuvant chemotherapy | ||||
no | 36(83.7) | 11(40.7) | 13.888 | 0.000 |
yes | 7(16.3) | 16(59.3) | ||
CA125(U/L) | 874.35 ± 1268.85 | 1558.4 ± 1632.69 | 2.655 | 0.054 |
HE4(pmol/L) | 313.06 ± 263.33 | 606.15 ± 356.95 | -3.945 | 0.000 |